Skip to content

Screener

Eligibility screening

Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostat…

Sponsored by AmgenStudy detailsClinicalTrials.gov

23 US sites in AZ, CA, CO, DE +12

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.